4-Formylpyridine

4-Formylpyridine

SCHEMBL28111835

C=O.O=Cc1ccncc1.O=Cc1ccncc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
CYP2A6 P11509 2/20 0.46
JUN P05412 1/20 0.44
NFKB1 P19838 1/20 0.44
HSD17B10 Q99714 1/20 0.42
ALDH5A1 P51649 1/20 0.42
ABAT P80404 1/20 0.42
KDM4E B2RXH2 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 2/20 0.39
MAPK1 P28482 2/20 0.39
HSP90AA1 P07900 1/20 0.39
XBP1 P17861 1/20 0.39
HTT P42858 1/20 0.39
CYP19A1 P11511 1/20 0.38
CYP11B2 P19099 1/20 0.38
CGAS Q8N884 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Formylpyridine SCHEMBL462293 0.94
4-Formylpyridine SCHEMBL28473 0.94
4-Formylpyridine SCHEMBL27750218 0.92 ALDH1A1 (0.48) ALDH1A1CYP2A6JUNNFKB1HSD17B10
4-Formylpyridine SCHEMBL4614337 0.92
4-Formylpyridine SCHEMBL1530881 0.92
4-Formylpyridine SCHEMBL29954274 0.92
4-Formylpyridine SCHEMBL6715614 0.92
4-Formylpyridine SCHEMBL6362259 0.92
4-Formylpyridine SCHEMBL28425267 0.92
4-Formylpyridine SCHEMBL27523098 0.89 ALDH1A1 (0.46) ALDH1A1CYP2A6JUNNFKB1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103588769-B The synthesis of pyrazoline-thiazolinone analog derivative that one class is novel and the application in cancer therapy drug NANJING UNIVERSITY (CN) 2016-11-30 CN disclosed